↓ Skip to main content

Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo controlled trial

Overview of attention for article published in Trials, May 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo controlled trial
Published in
Trials, May 2022
DOI 10.1186/s13063-022-06356-z
Pubmed ID
Authors

M. Waibel, H. E. Thomas, J. M. Wentworth, J. J. Couper, R. J. MacIsaac, F. J. Cameron, M. So, B. Krishnamurthy, M. C. Doyle, T. W. Kay

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 12%
Student > Master 2 8%
Student > Bachelor 1 4%
Unspecified 1 4%
Student > Doctoral Student 1 4%
Other 1 4%
Unknown 17 65%
Readers by discipline Count As %
Medicine and Dentistry 3 12%
Biochemistry, Genetics and Molecular Biology 2 8%
Nursing and Health Professions 2 8%
Social Sciences 1 4%
Unspecified 1 4%
Other 0 0%
Unknown 17 65%